Clinical trials
Phase 3 Myasthenia Gravis trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 2 |
| 2019 | 6 |
| 2020 | 1 |
| 2021 | 8 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 6 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 10 |
| Recruiting | 4 |
| Terminated | 4 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UCB Biopharma SRL | 7 |
| argenx | 6 |
| Alexion Pharmaceuticals, Inc. | 5 |
| Hoffmann-La Roche | 2 |
| Immunovant Sciences GmbH | 2 |
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| Cartesian Therapeutics | 1 |
| Catalyst Pharmaceuticals, Inc. | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myasthenia Gravis | 35 |
| Autoimmune Diseases | 1 |
| Thymoma | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.